ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 221 filers reported holding ALKERMES PLC in Q3 2021. The put-call ratio across all filers is 2.83 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $388,120 | -11.2% | 12,400 | -20.0% | 0.07% | +2.9% |
| Q1 2023 | $436,945 | +7.9% | 15,500 | 0.0% | 0.07% | +4.5% |
| Q4 2022 | $405,015 | +17.1% | 15,500 | 0.0% | 0.07% | +10.0% |
| Q3 2022 | $346,000 | -25.1% | 15,500 | 0.0% | 0.06% | -25.0% |
| Q2 2022 | $462,000 | +13.2% | 15,500 | 0.0% | 0.08% | +1.3% |
| Q1 2022 | $408,000 | +13.0% | 15,500 | 0.0% | 0.08% | 0.0% |
| Q4 2021 | $361,000 | -24.5% | 15,500 | 0.0% | 0.08% | -24.8% |
| Q3 2021 | $478,000 | -37.1% | 15,500 | -50.0% | 0.10% | -33.1% |
| Q2 2021 | $760,000 | – | 31,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |